Advertisement
Screener

Indivior Pharmaceuticals, Inc. (SUPN) Other, 2012

Indivior Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2012-11-02: Form 10-Q; Item Shares outstanding as of 2012-10-31; As filed 24,530,358.
  • 2012-08-13: Form 10-Q; Item Shares outstanding as of 2012-07-31; As filed 24,464,112.
  • 2012-06-08: Form 10-Q; Item Shares outstanding as of 2012-05-31; As filed 24,382,779.
  • 2012-06-08: Form 10-Q; Item Current in its reporting; As filed No.
FiledFormItemAs filed
2012-11-0210-QShares outstanding as of 2012-10-3124,530,358
2012-08-1310-QShares outstanding as of 2012-07-3124,464,112
2012-06-0810-QShares outstanding as of 2012-05-3124,382,779
2012-06-0810-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38